Mobile Cardiac Telemetry Global Market Report 2026

Mobile cardiac telemetry is a non-invasive ambulatory cardiac monitoring solution in which patients wear a compact, portable sensor patch that continuously captures and transmits electrocardiogram data through cellular communication networks to a centralized monitoring facility. Using automated arrhythmia detection algorithms, this technology identifies and reports asymptomatic or intermittent cardiac abnormalities, including atrial fibrillation, in real time, enabling extended diagnostic monitoring over several weeks.

The primary components of mobile cardiac telemetry include devices, software, and services. Devices consist of wearable cardiac monitoring equipment that continuously captures and transmits a patient's heart rhythm in real time, supporting remote clinical evaluation and the early identification of cardiac abnormalities. These solutions are designed for both short-term monitoring and long-term monitoring. Their applications include atrial fibrillation monitoring, bradycardia monitoring, tachycardia monitoring, and other cardiac arrhythmias, and they are utilized by hospitals, cardiology clinics, ambulatory surgical centers, home healthcare settings, and diagnostic centers.

Tariffs are influencing the mobile cardiac telemetry market by increasing the expense of imported wearable sensors, semiconductor components, wireless communication modules, and monitoring hardware needed for device manufacturing. This is placing added cost pressures on hospitals, cardiology clinics, and diagnostic service providers, particularly in regions dependent on imported medical electronics such as North America, Europe, and Asia-Pacific. Hardware-focused segments, including patch-based cardiac monitoring devices and portable telemetry systems, are facing the strongest effects due to their dependence on global component supply chains. However, tariffs are also encouraging domestic production, supplier diversification, and increased investment in regional healthcare technology manufacturing ecosystems.

The mobile cardiac telemetry market research report is one of a series of new reports from The Business Research Company that provides mobile cardiac telemetry market statistics, including mobile cardiac telemetry industry global market size, regional shares, competitors with a mobile cardiac telemetry market share, detailed mobile cardiac telemetry market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cardiac telemetry industry. This mobile cardiac telemetry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mobile cardiac telemetry market size has grown strongly in recent years. It will grow from $1.67 billion in 2025 to $1.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases and cardiac arrhythmias, rising demand for remote cardiac monitoring solutions, growing adoption of ambulatory healthcare services, expanding elderly population requiring continuous heart monitoring, increasing healthcare provider focus on early detection of cardiac abnormalities.

The mobile cardiac telemetry market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising adoption of home-based cardiac monitoring services, increasing demand for real-time cardiac event detection, growing integration of advanced wearable sensors in cardiac monitoring devices, expanding use of remote patient monitoring platforms, increasing investment in decentralized and value-based cardiac care models. Major trends in the forecast period include increasing adoption of wearable cardiac monitoring patches for continuous remote heart rhythm tracking, growing demand for real-time arrhythmia detection and prolonged cardiac monitoring solutions, rising deployment of cellular-enabled mobile cardiac telemetry systems for remote patient monitoring, increasing preference for non-invasive ambulatory cardiac monitoring over traditional diagnostic methods, growing focus on compact and patient-friendly cardiac monitoring devices for home-based care.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the mobile cardiac telemetry market going forward. Cardiovascular diseases are a group of conditions that impact the heart and blood vessels, including coronary artery disease, heart failure, stroke, and cardiac arrhythmias. The prevalence of cardiovascular diseases is increasing due to aging populations, sedentary lifestyles, rising obesity levels, and the growing occurrence of diabetes and hypertension, which continue to expand the number of individuals requiring long-term cardiac monitoring and care. As the burden of cardiovascular diseases rises, the demand for mobile cardiac telemetry is increasing due to its ability to provide continuous remote ECG monitoring, enable early detection of arrhythmias, facilitate timely clinical intervention, and improve long-term cardiac care. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, 919,032 people died from cardiovascular disease in the United States in 2023, representing 1 in every 3 deaths, while one person died from cardiovascular disease every 34 seconds. Therefore, the increasing prevalence of cardiovascular diseases is supporting the growth of the mobile cardiac telemetry market.

Leading companies operating in the mobile cardiac telemetry market are focusing on developing advanced solutions, including integrated ambulatory cardiac monitoring solutions, to enhance remote cardiac diagnostics and clinical workflow efficiency. Ambulatory cardiac monitoring solutions are wearable diagnostic systems that continuously capture a patient's heart activity during regular daily activities outside a clinical environment, supporting the early identification of cardiac rhythm abnormalities and enabling timely clinical intervention. For example, in May 2024, VivaLNK Inc., a US-based biometric technology company, launched its Turnkey Ambulatory Cardiac Monitoring Solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution combines VivaLNK's wearable electrocardiogram (ECG) sensor technology with a cloud-based platform, real-time data transmission capabilities, and clinical workflow functionalities, enabling healthcare providers and diagnostic service organizations to deliver scalable remote cardiac monitoring solutions.

In December 2024, SmartCardia SA, a Switzerland-based manufacturer of wearable ECG monitoring devices and mobile cardiac telemetry solutions, acquired Cardiomedix Inc. for an undisclosed value. Through this acquisition, SmartCardia aims to broaden its end-to-end mobile cardiac telemetry and remote cardiac monitoring services across the United States by combining wearable ECG technology with an integrated diagnostic platform. Cardiomedix Inc. is a US-based company specializing in ambulatory cardiac monitoring services, including mobile cardiac telemetry and remote cardiac diagnostic solutions for identifying and managing cardiac arrhythmias.

Major companies operating in the mobile cardiac telemetry market report are iRhythm Technologies Inc., Philips, Medtronic plc, Abbott Laboratories, AliveCor Inc., Fukuda Denshi Co. Ltd., VitalConnect Inc., ScottCare Corporation, Medicalgorithmics S.A., Bittium Corp., Vivalink, Biotricity Inc., Schiller AG, ACS Diagnostics (Applied Cardiac Systems), InfoBionic.ai, Qardio Inc., SmartCardia SA, Aerotel Medical Systems Ltd., Norav Medical Ltd., CardiacSense Ltd., Vector Remote Care LLC, Myocardial Solutions Inc.

North America was the dominant region in the mobile cardiac telemetry market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the mobile cardiac telemetry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mobile cardiac telemetry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mobile cardiac telemetry market consists of revenues earned by entities by providing services such as continuous real-time ECG monitoring, remote arrhythmia detection, wireless cardiac data transmission, physician alert notifications, and diagnostic reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The mobile cardiac telemetry market also includes sales of wearable ECG telemetry monitors, wireless ECG transmitters, adhesive ECG patches, sensor leads, charging docks, and related telemetry accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mobile Cardiac Telemetry Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mobile cardiac telemetry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mobile cardiac telemetry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile cardiac telemetry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Devices; Software; Services
• 2) By Duration Of Monitoring: Short Term Monitoring; Long Term Monitoring
• 3) By Application: Atrial Fibrillation Monitoring; Bradycardia Monitoring; Tachycardia Monitoring; Other Cardiac Arrhythmias
• 4) By End User: Hospitals; Cardiology Clinics; Ambulatory Surgical Centers; Home Healthcare Settings; Diagnostic Centers
• Subsegments:
• 1) By Devices: Wearable Cardiac Monitoring Devices; Portable Cardiac Monitoring Devices; Patch Based Cardiac Monitoring Devices; Handheld Cardiac Monitoring Devices
• 2) By Software: Data Management Software; Cardiac Rhythm Analysis Software; Patient Monitoring Software; Cloud Based Monitoring Software
• 3) By Services: Hospital Based Monitoring; Independent Diagnostic Testing Facilities; Third Party Cardiac Monitoring Service Providers
• Companies Mentioned: iRhythm Technologies Inc.; Philips; Medtronic plc; Abbott Laboratories; AliveCor Inc.; Fukuda Denshi Co. Ltd.; VitalConnect Inc.; ScottCare Corporation; Medicalgorithmics S.A.; Bittium Corp.; Vivalink; Biotricity Inc.; Schiller AG; ACS Diagnostics (Applied Cardiac Systems); InfoBionic.ai; Qardio Inc.; SmartCardia SA; Aerotel Medical Systems Ltd.; Norav Medical Ltd.; CardiacSense Ltd.; Vector Remote Care LLC; Myocardial Solutions Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.